The North America Intravenous Infusion Pump Market would witness market growth of 7.8% CAGR during the forecast period (2021-2027).
A medical device, which transfers fluids like nutrients & medications, into a person’s circulatory system via an intravenous passage in fixed amounts is known as an intravenous infusion pump. The usage of intravenous infusion pumps helps in preventing medical errors. In addition, these infusion pumps are categorized by the usages like stationary use and portable use. Moreover, intravenous infusion pumps are majorly used in medical services centers like critical care, private centers, outpatient, and at-home settings. These infusion pumps also provide substantial benefits in comparison to the manual administration of fluids; these benefits include the capability of these pumps to transfer fluids at accurate programmed rates or automated intervals along with the ability to transfer fluids in a very small amount.
The high number of chronic diseases cases is one of the most crucial factors fueling the growth of the intravenous infusion pumps market in this region. Along with that, the strong medical infrastructure of the developed nations such as the US and Canada are also supporting the growth of the market. The prevalence of cancer and diabetes in this region is comparatively high in this region, which is contributing to the high demand for these infusion pumps in the region.
The robust presence of the key market players in this region is supporting the overall growth of the regional intravenous infusion pumps market during the forecast period. In addition, the supportive reimbursement policies in this region are promoting various medical centers to adopt advanced systems like intravenous infusion pumps for giving better treatment to the patients.
The US market dominated the North America Syringe Infusion Pumps Market by Country in 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $968.3 million by 2027. The Canada market is experiencing a CAGR of 10.1% during (2021 - 2027). Additionally, The Mexico market would witness a CAGR of 9.2% during (2021 - 2027).
Based on Type, the market is segmented into Volumetric Infusion Pumps, Syringe Infusion Pumps and Patient Controlled Analgesia Infusion Pumps. Based on Application, the market is segmented into Oncology, Parenteral Nutrition, Analgesia/Pain Management and Others. Based on End User, the market is segmented into Hospitals & Clinics, Home Healthcare and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Intravenous Infusion Pump Market is Estimated to Reach USD 8.2 Billion by 2027 at a CAGR of 8.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson & Johnson, B. Braun Melsungen AG, Medtronic PLC, F. Hoffmann-La Roche Ltd., Becton, Dickinson and Company, Baxter International, Inc., Terumo Corporation, Smiths Group PLC, Boston Scientific Corporation, and Micrel Medical Devices SA.
By Type
By Application
By End User
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 